Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trials with terazosin. General methods.

W D Sperzel, R R Luther, H N Glassman

    The American Journal of Medicine
    |May 23, 1986
    PubMed
    Summary

    Terazosin effectively lowered blood pressure in hypertensive patients across multiple clinical trials. The drug demonstrated efficacy and safety when used alone or with other antihypertensives.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Viability of Brucella suis on storage in liquid culture.

    American journal of veterinary research·2010
    Same author

    The management of severe chronic pain with a focus on new treatment modalities.

    Drugs of today (Barcelona, Spain : 1998)·2004
    Same author

    Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.

    Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2000
    Same author

    Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain.

    Regional anesthesia and pain medicine·2000
    Same author

    Effects of an N-type calcium channel antagonist (SNX 111; Ziconotide) on calcium-45 accumulation following fluid-percussion injury.

    Journal of neurotrauma·1999
    Same author

    Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.

    American journal of hypertension·1999

    Area of Science:

    • Pharmacology
    • Clinical Medicine
    • Cardiovascular Research

    Background:

    • Hypertension is a major global health concern requiring effective therapeutic agents.
    • Terazosin, an alpha-1 adrenergic blocker, has been investigated for its antihypertensive properties.

    Purpose of the Study:

    • To evaluate the efficacy and safety of terazosin in managing hypertension.
    • To assess terazosin's performance in various dosing regimens and in combination therapies.

    Main Methods:

    • Conducted multiple double-blind, controlled, and long-term follow-up clinical trials.
    • Included patients with supine diastolic blood pressure ≥ 95 mm Hg.
    • Employed dose titration, fixed-dose, and randomized withdrawal study designs.
    • Monitored blood pressure, pulse rate, body weight, laboratory variables, and adverse events.

    Main Results:

    • Terazosin demonstrated efficacy in reducing blood pressure across different study designs.
    • Evaluated safety parameters indicated a generally acceptable profile.
    • Dose-ranging studies explored optimal therapeutic levels from 1 to 40 mg daily.

    Conclusions:

    • Terazosin is an effective antihypertensive medication.
    • The drug is suitable for monotherapy and combination therapy in hypertensive patients.
    • Clinical trials confirmed terazosin's role in blood pressure management.

    Related Experiment Videos